| Medical Mutual | Oncology Value: Vyxeos® (daunorubicin and cytarabine – liposome) (Intravenous) | 2026-04-01 |
| Medical Mutual | Xenpozyme® (olipudase alfa) (Intravenous) | 2026-04-01 |
| Medical Mutual | Yervoy® (ipilimumab) (Intravenous) (EOV) | 2026-04-01 |
| Medical Mutual | Zynyz® (retifanlimab-dlwr) (Intravenous) (EOV) | 2026-04-01 |
| BCBS Premera WA AK Clinical | Lyme Disease Testing | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Interstitial Lung Disease (ILD) (09-J5000-48) | 2026-04-01 |
| BCBS Louisiana | Diaphragmatic/Phrenic Nerve Stimulation and Diaphragm Pacing Systems | 2026-04-01 |
| BCBS Louisiana | Thermal Capsulorrhaphy as a Treatment of Joint Instability | 2026-04-01 |
| BCBS Louisiana | Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions | 2026-04-01 |
| BCBS Louisiana | Autologous Hematopoietic Cell Transplantation for Malignant Astrocytomas and Gliomas | 2026-04-01 |